Notice of Change to RFA-CA-17-006 "Cancer Immunologic Data Commons (CIDC) (U24)" to Include Collection and Analysis of Data for Specimens from Immunotherapy Trials for Pediatric Cancer Patients

Notice Number: NOT-CA-17-025

Key Dates
Release Date: January 27, 2017

Related Announcements
RFA-CA-17-006
NOT-CA-17-024

Issued by
National Cancer Institute (NCI)

Purpose

This Notice is to inform the scientific community that the National Cancer Institute (NCI) is amending RFA-CA-17-006 "Cancer Immunologic Data Commons (CIDC) (U24)" to include collection and analysis of data for specimens from immunotherapy trials for pediatric cancer patients.
This change reflects the expansion of the scope of the companion funding opportunity announcement (FOA), RFA-CA-17-005 "Cancer Immune Monitoring and Analysis Centers (CIMACs) (U24) , which will support a dedicated CIMAC to be focused on biospecimens from pediatric immunotherapy trials (through a related Notice, NOT-CA-17-024).

The following Sections of RFA-CA-17-006 are revised accordingly:

Part 1: Overview Information

Section 1. Funding Opportunity Purpose

Currently reads:

The purpose of this funding opportunity announcement (FOA) is to solicit applications for establishment of a Cancer Immunologic Data Commons (CIDC) to provide bioinformatics support as part of a Network for correlative studies in clinical trials involving cancer immunotherapy. The Network will encompass a single CIDC award (to be supported by this FOA) and up to three Cancer Immune Monitoring and Analysis Centers (CIMACs) (to be supported by a companion FOA, RFA-CA-17-005).

Modified to read:

The purpose of this funding opportunity announcement (FOA) is to solicit applications for establishment of a Cancer Immunologic Data Commons (CIDC) to provide bioinformatics support as part of a Network for correlative studies in clinical trials involving cancer immunotherapy. The Network will encompass a single CIDC award (to be supported by this FOA) and up to three Cancer Immune Monitoring and Analysis Centers (CIMACs) as well as an additional CIMAC focusing on pediatric immunotherapy (the Pediatric CIMAC) (to be supported by a companion FOA, RFA-CA-17-005).

Section II. Award Information

Funds Available and Anticipated Number of Awards

Currently reads:

The NCI intends to fund a single Cancer Immunologic Data Commons (CIDC) award, corresponding to $650,000 in direct costs in fiscal year 2017.

Modified to read:

The NCI intends to fund a single Cancer Immunologic Data Commons (CIDC) award, corresponding to $900,000 in direct costs in fiscal year 2017.

Award Budget

Currently reads:

Budget is limited to no more than $650,000 in direct costs for any budget year.

Modified to read:

Budget is limited to no more than $900,000 in direct costs for any budget year.

Inquiries

Please direct all inquiries to:

Magdalena Thurin, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5973
E-mail: thurinm@mail.nih.gov